Medtronic plc
HealthcareNYSE:MDT · New York Stock Exchange
-$0.05 today
Vol 3.43M · Avg 9.86M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $4.8B +3.1% | $4.7B +27.6% | $3.7B -2.9% | $3.8B -25.2% | $5.1B | $498.8M | $487.6M | $476.4M |
| Depreciation & Amortization | $3.0B +3.4% | $2.9B +8.1% | $2.6B -1.9% | $2.7B -0.4% | $2.7B | $1.2B | $374.2M | $1.2B |
| Deferred Income Tax | $51.0M +116.1% | -$316.0M +37.8% | -$508.0M -124.8% | -$226.0M +62.6% | -$604.0M | $1.2B | $1.4B | -$1.5B |
| Stock-Based Compensation | $457.0M +6.5% | $429.0M +9.2% | $393.0M +10.7% | $355.0M -1.1% | $359.0M | $623.4M | $489.0M | $354.6M |
| Change in Working Capital | -$1.4B -35.0% | -$1.1B -117.8% | -$484.0M +49.9% | -$967.0M -8.8% | -$889.0M | $484.8M | $350.4M | -$1.6B |
| Accounts Receivables | -$200.0M +53.8% | -$433.0M -10.7% | -$391.0M +32.1% | -$576.0M -20.8% | -$477.0M | $1.3B | $592.6M | $1.3B |
| Inventory | -$404.0M -38.4% | -$292.0M -110.1% | -$139.0M +85.2% | -$939.0M -67.7% | -$560.0M | $854.4M | $1.0B | $1.2B |
| Accounts Payables | $46.0M -78.0% | $209.0M -46.5% | $391.0M -43.8% | $696.0M +226.8% | $213.0M | $657.0M | $948.2M | -$1.5B |
| Other Working Capital | -$865.0M -60.8% | -$538.0M -55.9% | -$345.0M -133.1% | -$148.0M -127.7% | -$65.0M | $1.3B | $567.4M | $1.3B |
| Other Non-Cash Items | $450.0M +3.9% | $433.0M -59.3% | $1.1B +168.4% | $396.0M -44.3% | $711.0M | $1.2B | $1.4B | -$1.5B |
| Operating Cash Flow | $7.3B +4.1% | $7.0B +3.8% | $6.8B +12.4% | $6.0B -17.8% | $7.3B | $5.5B | $7.2B | $8.9B |
| Capital Expenditures | -$1.9B -2.4% | -$1.9B -17.1% | -$1.6B -8.8% | -$1.5B -6.7% | -$1.4B | $1.0B | $664.0M | $1.4B |
| Acquisitions (Net) | -$406.0M -314.3% | -$98.0M +53.6% | -$211.0M +88.7% | -$1.9B -1951.6% | -$91.0M | $769.0M | $937.0M | $1.1B |
| Purchases of Investments | -$8.7B -6.1% | -$8.2B -6.2% | -$7.7B -3.1% | -$7.5B +24.0% | -$9.9B | $578.6M | $444.2M | $1.4B |
| Sales of Investments | $8.1B -4.6% | $8.5B +14.2% | $7.4B +1.3% | $7.3B -24.2% | $9.7B | $1.0B | $822.2M | $318.2M |
| Other Investing Activities | -$4.0M +98.4% | -$249.0M +4.6% | -$261.0M -6625.0% | $4.0M +140.0% | -$10.0M | $862.8M | $616.4M | $370.0M |
| Investing Cash Flow | -$2.9B -51.5% | -$1.9B +18.1% | -$2.4B +32.3% | -$3.5B -110.5% | -$1.7B | $3.1B | $4.8B | $6.4B |
| Debt Repayment | -$1.2B -154.9% | $2.1B +99.3% | $1.1B +279.4% | -$598.0M -59700.0% | -$1.0M | $602.4M | $680.8M | $759.2M |
| Common Stock Issued | $516.0M +1.6% | $508.0M +78.9% | $284.0M -7.8% | $308.0M -28.2% | $429.0M | $610.8M | $778.8M | $946.8M |
| Common Stock Repurchased | -$1.0B +68.0% | -$3.2B -51.3% | -$2.1B -231.5% | -$645.0M +74.6% | -$2.5B | $486.2M | $351.8M | -$1.6B |
| Dividends Paid | -$3.6B -1.4% | -$3.6B +2.1% | -$3.7B -1.4% | -$3.6B -6.9% | -$3.4B | -$1.6B | $535.2M | $613.6M |
| Other Financing Activities | $582.0M +416.3% | -$184.0M -6033.3% | -$3.0M +97.0% | -$101.0M -162.0% | $163.0M | $720.0M | -$1.6B | $1.3B |
| Financing Cash Flow | -$4.8B -8.9% | -$4.4B +2.0% | -$4.5B +10.3% | -$5.0B +7.0% | -$5.3B | $10.5B | $12.2B | $13.9B |
| Effect of Forex Changes | $85.0M -54.8% | $188.0M +181.7% | -$230.0M -194.7% | $243.0M +205.7% | -$230.0M | $1.4B | $1.3B | $1.1B |
| Net Change in Cash | -$269.0M -128.8% | $934.0M +460.6% | -$259.0M +88.1% | -$2.2B -1894.2% | $121.0M | -$15.5B | $3.2B | $4.9B |
| Free Cash Flow | $5.4B +4.6% | $5.2B -0.3% | $5.2B +13.5% | $4.6B -23.4% | $6.0B | $14.3B | $8.6B | -$16.8B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$129.95B
Stryker Corporation
NYSE:SYK
$120.03B
Bristol-Myers Squibb Company
NYSE:BMY
$116.51B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$112.66B
GSK plc
NYSE:GSK
$106.56B
Sanofi
NASDAQ:SNY
$106.46B
McKesson Corporation
NYSE:MCK
$94.83B
HCA Healthcare, Inc.
NYSE:HCA
$85.78B
Boston Scientific Corporation
NYSE:BSX
$69.84B
Edwards Lifesciences Corporation
NYSE:EW
$48.81B
SEC Filings
Recent regulatory filings
No filings found.
Does MDT generate free cash flow?
Medtronic plc (MDT) generated $5.43B of free cash flow in fiscal 2026.
How much operating cash flow does MDT produce?
Operating cash flow was $7.33B, before capital expenditures of $1.90B.
Explore More
Continue the stock analysis
Jump to another research area for this company.